1. Platelet associated IgG may be related with thrombocytopenia in patients with myelodysplastic syndromes
- Author
-
Vagner Castro, Sara Teresinha Olalla Saad, Samuel de Souza Medina, Luis Gustavo Romani Fernandes, and Simone Cristina Olenscki Gilli
- Subjects
Blood Platelets ,Male ,medicine.medical_specialty ,Platelet associated IgG ,Cancer Research ,Immunofluorescence ,Gastroenterology ,Internal medicine ,Prevalence ,medicine ,Humans ,Platelet indices ,In patient ,Platelet ,Prospective Studies ,Mean platelet volume ,Prospective cohort study ,Aged ,medicine.diagnostic_test ,business.industry ,Myelodysplastic syndromes ,PIFT ,Hematology ,Middle Aged ,Prognosis ,medicine.disease ,Thrombocytopenia ,Oncology ,Fluorescent Antibody Technique, Direct ,International Prognostic Scoring System ,Glycocalicin index ,Immunoglobulin G ,Myelodysplastic Syndromes ,Immunology ,Female ,business ,Myelodysplastic syndrome - Abstract
Thrombocytopenia is common in patients with myelodysplastic syndromes (MDS) and immune destruction of platelets could be an important factor for its occurrence. We prospectively analyzed platelet-associated IgG (PAIgG) through platelet immunofluorescence test (PIFT), mean platelet volume (MPV), platelet size deviation width (PDW) and glycocalicin index (GCI) of 54 patients with MDS, classified according to the International Prognostic Scoring System (IPSS). Thrombocytopenia (platelet count
- Published
- 2012
- Full Text
- View/download PDF